Issues
First issue features:
- Our first overview article published in Toxicologic Pathology
- Key regulatory discussions, including engagement with major regulatory authorities
- Highlights from our first public webinars, with more than 170 and 120 participants
- Meet the people behind VICT3R in our new interview series
- Expanding industry and academic collaborations to advance VCGs
Check out the web version.